FRANKLIN RESOURCES INC

Holdings History for Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT)

Symbol: APLT
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 2,003,400 shares
Security Ownership %: 1.7%

Shares, Excluding Options vs Price

Value, Excluding Options

Franklin Resources, Inc. ownership in Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT)

27 Jan 2025 - Franklin Resources, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,003,400 shares of Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT). This represents 1.7% ownership of the company. In their previous filing dated 31 Oct 2024, FRANKLIN RESOURCES INC had reported owning 6,800,910 shares, indicating a decrease of +71%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Franklin Resources, Inc.	1.7%	-70%	$781,326	2,003,400	-4,797,510	-71%	$0.39	13G/A	31 Dec 2024	27 Jan 2025, 12:48
Franklin Resources, Inc.	5.9%		$2,652,355	6,800,910			$0.39	13G/A	30 Sep 2024	31 Oct 2024, 12:42

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-0%	$0	0	-2,003,338	-100%	$0.10	Q4 2025
30 Sep 2025	0%	0%	$1,211,819	2,003,338	0		$0.60	Q3 2025
30 Jun 2025	0%	0%	$623,238	2,003,338	0		$0.31	Q2 2025
31 Mar 2025	0%	0%	$979,432	2,003,338	-62		$0.49	Q1 2025
31 Dec 2024	0%	-0%	$1,715,311	2,003,400	-4,797,510	-71%	$0.86	Q4 2024
30 Sep 2024	0.02%	-0.01%	$60,460,090	6,800,910	-3,412,035	-33%	$8.89	Q3 2024
30 Jun 2024	0.01%	-0%	$47,694,453	10,212,945	-351,400	-3.3%	$4.67	Q2 2024
31 Mar 2024	0.02%	+0.01%	$71,837,546	10,564,345	+3,546,433	+51%	$6.80	Q1 2024
31 Dec 2023	0.01%	-0%	$23,510,005	7,017,912	-929,100	-12%	$3.35	Q4 2023
30 Sep 2023	0.01%	0%	$19,788,060	7,947,012	+280	+0%	$2.49	Q3 2023
30 Jun 2023	0%	+0%	$10,171,817	7,946,732	+3,171,248	+66%	$1.28	Q2 2023
31 Mar 2023	0%	0%	$3,873,395	4,775,484	0		$0.81	Q1 2023
31 Dec 2022	0%	0%	$3,629,368	4,775,484	0		$0.76	Q4 2022
30 Sep 2022	0%	0%	$4,442,000	4,775,484	0		$0.93	Q3 2022
30 Jun 2022	0%	+0%	$4,528,000	4,775,484	+3,179,934	+199%	$0.95	Q2 2022
31 Mar 2022	0%	+0%	$3,367,000	1,595,550	+470,256	+42%	$2.11	Q1 2022
31 Dec 2021	0%	+0%	$10,071,000	1,125,294	+291,012	+35%	$8.95	Q4 2021
30 Sep 2021	0.01%	+0%	$13,849,000	834,282	+4,300	+0.52%	$16.60	Q3 2021
30 Jun 2021	0.01%	+0%	$17,247,000	829,982	+81,000	+11%	$20.78	Q2 2021
31 Mar 2021	0.01%	+0%	$14,047,000	748,982	+383,700	+105%	$18.75	Q1 2021
31 Dec 2020	0%	0%	$8,040,000	365,282	+14	+0%	$22.01	Q4 2020
30 Sep 2020	0%	0%	$7,583,000	365,268	0		$20.76	Q3 2020
30 Jun 2020		0%	$9,365,000	365,268	0		$25.64 ^*	Q2 2020
31 Mar 2020	0.01%	+0.01%	$11,113,000	339,961	+339,961	NEW	$32.69	Q1 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.